DiaMedica Therapeutics Unearned Premium on Insurance Contract (Quarterly) Insights

DiaMedica Therapeutics, Inc. (DMAC)

8.56 +0.25 (+3.01%) USD | NASDAQ | Feb 24, 12:55

View Unearned Premium on Insurance Contract (Quarterly) for DMAC.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Unearned Premium on Insurance Contract (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Unearned Premium on Insurance Contract (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Unearned Premium on Insurance Contract (Quarterly) Benchmarks

Start Trial

XOMA Royalty Corp.	--
Avantor, Inc.	--
ACADIA Pharmaceuticals, Inc.	--
Alnylam Pharmaceuticals, Inc.	--
Savara, Inc.	--